je.st
news
Navidea Biopharmaceuticals Downgraded by Zacks Investment Research
2015-11-26 07:50:52| Biotech - Topix.net
According to Zacks, "Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek , AZD4694 and RIGScan .
Tags: research
investment
downgraded
zacks
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||